Working… Menu

Af Ablation In Brady-Tachy Syndrome (Alternative)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00740272
Recruitment Status : Terminated (Slow recruitment)
First Posted : August 22, 2008
Last Update Posted : February 4, 2019
Information provided by (Responsible Party):
Abbott Medical Devices

Brief Summary:

The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden.

The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.

Condition or disease Intervention/treatment Phase
Brady-tachy Syndrome Procedure: AF ablation + pacemaker implantation Procedure: Pacemaker implantation Not Applicable

Detailed Description:
The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 38 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Af Ablation In Brady-Tachy Syndrome
Study Start Date : March 2008
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 1
AF ablation + pacemaker
Procedure: AF ablation + pacemaker implantation
regular pacemaker implantation and concomitant AF ablation procedure (PV isolation)

Active Comparator: 2
Procedure: Pacemaker implantation
regular pacemaker implantation

Primary Outcome Measures :
  1. AF burden [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. Quality of life [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • paroxystic AF
  • symptomatic pauses (>5s at night or 3s during daytime)

Exclusion Criteria:

  • permanent AF
  • age > 80 y
  • pregnant women
  • minors

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00740272

Layout table for location information
Hôpital St joseph
Marseille, France
Rouen, France
Clinique Pasteur
Toulouse, France
Sponsors and Collaborators
Abbott Medical Devices

Layout table for additonal information
Responsible Party: Abbott Medical Devices Identifier: NCT00740272     History of Changes
Other Study ID Numbers: SJM-FR01
First Posted: August 22, 2008    Key Record Dates
Last Update Posted: February 4, 2019
Last Verified: February 2019
Keywords provided by Abbott Medical Devices:
brady-tachy syndrome
AF ablation
Additional relevant MeSH terms:
Layout table for MeSH terms
Sick Sinus Syndrome
Pathologic Processes
Arrhythmia, Sinus
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Heart Block
Cardiac Conduction System Disease